sorafenib has been researched along with n-methyl-4-(4-(3-(trifluoromethyl)benzamido)phenoxy)picolinamide in 1 studies
Studies (sorafenib) | Trials (sorafenib) | Recent Studies (post-2010) (sorafenib) | Studies (n-methyl-4-(4-(3-(trifluoromethyl)benzamido)phenoxy)picolinamide) | Trials (n-methyl-4-(4-(3-(trifluoromethyl)benzamido)phenoxy)picolinamide) | Recent Studies (post-2010) (n-methyl-4-(4-(3-(trifluoromethyl)benzamido)phenoxy)picolinamide) |
---|---|---|---|---|---|
6,520 | 730 | 5,251 | 6 | 0 | 6 |
Protein | Taxonomy | sorafenib (IC50) | n-methyl-4-(4-(3-(trifluoromethyl)benzamido)phenoxy)picolinamide (IC50) |
---|---|---|---|
Vascular endothelial growth factor receptor 2 | Homo sapiens (human) | 0.46 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Cao, LQ; Liu, H; Lv, BB; Shi, L; Wang, R; Wang, XY; Xu, YG; Xue, JY; You, YY | 1 |
1 other study(ies) available for sorafenib and n-methyl-4-(4-(3-(trifluoromethyl)benzamido)phenoxy)picolinamide
Article | Year |
---|---|
Discovery of novel VEGFR-2 inhibitors embedding 6,7-dimethoxyquinazoline and diarylamide fragments.
Topics: Amides; Antineoplastic Agents; Cell Proliferation; Dose-Response Relationship, Drug; Drug Discovery; Drug Screening Assays, Antitumor; Hep G2 Cells; Humans; MCF-7 Cells; Molecular Docking Simulation; Molecular Structure; Protein Kinase Inhibitors; Quinazolines; Structure-Activity Relationship; Vascular Endothelial Growth Factor Receptor-2 | 2021 |